兔抗牛IgG(H+L)抗血清小鼠*Ⅳ(FⅣ)ELISA Kit Mouse coagulation factor Ⅳ,FⅣ ELISA Kit
小鼠*Ⅲ(FⅢ)ELISA Kit Mouse coagulation factor Ⅲ,FⅢ ELISA Kit
小鼠*Ⅰ(FⅠ)ELISA Kit Mouse coagulation factor Ⅰ,FⅠ ELISA Kit
我司提供的兔抗牛IgG(H+L)抗血清質(zhì)量好,折扣低,貨期短!保證您購(gòu)買到的都是批次的產(chǎn)品!
產(chǎn)品名稱:
英文名稱:Rabbit anti bovine IgG (H+L) antiserum
規(guī)格及單位:1ml/10ml
產(chǎn)品型號(hào):YS-XQ0449
產(chǎn)地:進(jìn)口/國(guó)產(chǎn)
用法:血清由冰凍狀態(tài)在常溫下*融化成液體,搖均勻后放置10-30分鐘待結(jié)塊蛋白質(zhì)沉底后即可使用。
注意事項(xiàng):有少量蛋白質(zhì)結(jié)塊析出不影響使用。未融化或融化未經(jīng)搖勻的血清禁止直接放入高溫水浴內(nèi)加溫。減少血清重復(fù)凍融。血清在室溫或4℃冰箱內(nèi)放置過久會(huì)影響促細(xì)胞生*果。
的保存方法:
(1)*保存的血清必須儲(chǔ)存于-20℃ - 70℃ 低溫冰箱中.4℃冰箱中保存時(shí)間切勿超過1個(gè)月.由于血清結(jié)冰時(shí)體積會(huì)增加約10%,因此,血清在凍入低溫冰箱前,必須預(yù)留一定體積空間,否則易發(fā)生污染或玻璃瓶?jī)隽?
(2)一般廠商提供的血清為無(wú)菌,無(wú)需再過濾除菌.如發(fā)現(xiàn)血清有懸浮物,則可將血清加入培養(yǎng)液內(nèi)一起過濾,切勿直接過濾血清.
(3)血清解凍: 瓶裝血清解凍需采用逐步解凍法:-20℃ 至 -70℃ 低溫冰箱中的血清放入4℃冰箱中溶解1天.然后移入室溫,待全部溶解后再分裝.在溶解過程中需不斷輕輕搖晃均勻(小心勿造成氣泡),使溫度與成分均一,減少沉淀的發(fā)生.切勿直接將血清從-20℃進(jìn)入37℃解凍,這樣因溫度改變太大,容易造成蛋白質(zhì)凝集而出現(xiàn)沉淀。
人利什曼原蟲(Leishmania)抗體(IgG)免疫試劑盒 進(jìn)口、分裝 英文名稱: Human Leishmania antibody IgG ELISA Kit
人利鉀尿肽(KP)免疫試劑盒 現(xiàn)貨供應(yīng) 英文名稱: Human kaliuretic peptide,KP ELISA Kit
人李斯特菌抗體(IgM)免疫試劑盒 *直銷 英文名稱: Human Listeria antibody,IgM ELISA Kit
人李斯特菌抗體(IgG)免疫試劑盒 進(jìn)口、組裝 英文名稱: Human Listeria antibody IgG ELISA Kit
人冷誘導(dǎo)RNA結(jié)合蛋白(CIRBP)免疫試劑盒 進(jìn)口、分裝 英文名稱: Human CIRBP ELISA Kit
人冷球蛋白(CG)免疫試劑盒 現(xiàn)貨供應(yīng) 英文名稱: Human Cryoglobulin,CG ELISA Kit
人類似RIKEN cDNA 4931408D14 基因 免疫試劑盒 *直銷 英文名稱: human similar to RIKEN cDNA 4931408D14 gene ELISA kit
人類似cDNA順序BC027382 免疫試劑盒 進(jìn)口、組裝 英文名稱: human similar to cDNA sequence BC027382 ELISA Kit
人類免疫缺陷病毒(HIV)1+2 抗體 免疫試劑盒 進(jìn)口、分裝 英文名稱: Human immunodeficiency virus (HIV) 1+2 antibody ELISA Kit
人類肌腱蛋白c(TNC)免疫試劑盒 現(xiàn)貨供應(yīng) 英文名稱: Human Tenascin c,TNC ELISA Kit
人類肌腱蛋白(TN)免疫試劑盒 *直銷 英文名稱: Human Tenascin,TN ELISA Kit
人類固醇細(xì)胞抗體(SCA)免疫試劑盒 進(jìn)口、組裝 英文名稱: Human steroid cell autoantibody,SCA ELISA Kit
人類風(fēng)濕因子(RF)抗體(IgM)免疫試劑盒 進(jìn)口、分裝 英文名稱: Human rheumatoid factor(RF)antibody(IgM)ELISA kit
人類風(fēng)濕因子(RF)抗體(IgG)免疫試劑盒 現(xiàn)貨供應(yīng) 英文名稱: Human RF antibody IgG ELISA Kit
人類風(fēng)濕因子(RF)抗體(IgA)免疫試劑盒 *直銷 英文名稱: Human rheumatoid factor antibody IgA ELISA Kit
人類風(fēng)濕因子(RF)免疫試劑盒 進(jìn)口、組裝 英文名稱: Human rheumatoid factor,RF ELISA Kit
人類泛素蛋白ISG15 免疫試劑盒 進(jìn)口、分裝 英文名稱: Human ubiquitin-like modifier(ISG15)ELISA kit
人類白細(xì)胞抗原G(HLA-G)免疫試劑盒 現(xiàn)貨供應(yīng) 英文名稱: Human HLA-G ELISA Kit
人類白細(xì)胞抗原E(HLA-E)免疫試劑盒 *直銷 英文名稱: Human HLA-E ELISA Kit
人類白細(xì)胞抗原B27(HLA-B27)免疫試劑盒 進(jìn)口、組裝 英文名稱: Human leucocyte antigen B27,HLA-B27 ELISA Kit
人雷帕霉素靶蛋白(mTOR)免疫試劑盒 進(jìn)口、分裝 英文名稱: Human mammalian target of rapamyein,mTOR ELISA Kit
人酪氨酰tRNA合成酶(YARS)免疫試劑盒 現(xiàn)貨供應(yīng) 英文名稱: Human tyrosyl-tRNA synthetase,YARS ELISA kit
人酪氨酰DNA 磷酸二酯酶1(TDP1)免疫試劑盒 *直銷 英文名稱: Human Tyrosyl-DNA Phosphodiesterase 1,TDP1 ELISA Kit
人*羥化酶(TH)免疫試劑盒 進(jìn)口、組裝 英文名稱: Human tyrosine hydroxylase,TH ELISA Kit
人*激酶2(Tyk-2)免疫試劑盒 進(jìn)口、分裝 英文名稱: Human tyrosine kinase2,Tyk-2 ELISA Kit
人*蛋白激酶受體TYRO3(TYRO3)免疫試劑盒 現(xiàn)貨供應(yīng) 英文名稱: Human TYRO3 ELISA Kit
人蘭尼堿受體2(RYR2)免疫試劑盒 *直銷 英文名稱: Human RYR2 ELISA Kit
人蘭尼堿抗體免疫試劑盒 進(jìn)口、組裝 英文名稱: Human anti-ryanodine antibody ELISA Kit
人賴氨酰氧化酶免疫試劑盒 進(jìn)口、分裝 英文名稱: Human Protein-lysine 6-oxidase(LOX) ELISA kit
人賴氨酸特異性脫甲基酶5A(JARID1A)免疫試劑盒 現(xiàn)貨供應(yīng) 英文名稱: Human lysine-specific demethylase 5A,JARID1A ELISA kit
人醌NADH脫氫酶1(NQO1)免疫試劑盒 *直銷 英文名稱: Human NAD (P)H Dehydrogenase, Quinone 1 (NQO1)ELISA Kit
人跨膜結(jié)構(gòu)域4亞家族成員11(MS4A11)免疫試劑盒 進(jìn)口、組裝 英文名稱: human membrane-spanning 4-domains subfamily A member 11,MS4A11 ELISA Kit4-(n-nonyl) Benzeneboronic Acid (100 mg) B-(4-nonylphenyl)-boronic acid; 4-(n-nonyl) Benzeneboronic Acid
4-(n-nonyl) Benzeneboronic Acid (250 mg) B-(4-nonylphenyl)-boronic acid; 4-(n-nonyl) Benzeneboronic Acid
4-(n-nonyl) Benzeneboronic Acid (500 mg) B-(4-nonylphenyl)-boronic acid; 4-(n-nonyl) Benzeneboronic Acid
CAY10587 (1 mg) 4-[2-(2-methylphenyl)ethynyl]-benzenepropanoic acid; CAY10587
CAY10587 (10 mg) 4-[2-(2-methylphenyl)ethynyl]-benzenepropanoic acid; CAY10587
CAY10587 (25 mg) 4-[2-(2-methylphenyl)ethynyl]-benzenepropanoic acid; CAY10587
CAY10587 (5 mg) 4-[2-(2-methylphenyl)ethynyl]-benzenepropanoic acid; CAY10587
Anacardic Acid (1 mg) 2-hydroxy-6-pentadecyl-benzoic acid; 6-pentadecyl Salicylic Acid; Anacardic Acid
Anacardic Acid (10 mg) 2-hydroxy-6-pentadecyl-benzoic acid; 6-pentadecyl Salicylic Acid; Anacardic Acid
Anacardic Acid (5 mg) 2-hydroxy-6-pentadecyl-benzoic acid; 6-pentadecyl Salicylic Acid; Anacardic Acid
AGK2 (1 mg) 2-cyano-3-[5-(2,5-dichlorophenyl)-2-furanyl]-N-5-quinolinyl-2-propenamide; AGK2
AGK2 (10 mg) 2-cyano-3-[5-(2,5-dichlorophenyl)-2-furanyl]-N-5-quinolinyl-2-propenamide; AGK2
AGK2 (25 mg) 2-cyano-3-[5-(2,5-dichlorophenyl)-2-furanyl]-N-5-quinolinyl-2-propenamide; AGK2
AGK2 (5 mg) 2-cyano-3-[5-(2,5-dichlorophenyl)-2-furanyl]-N-5-quinolinyl-2-propenamide; AGK2
CAY10603 (1 mg) N-[4-[3-[[[7-(hydroxyamino)-7-oxoheptyl]amino]carbonyl]-5-isoxazolyl]phenyl]-1,1-dimethylethyl ester, carbamic acid; CAY10603
CAY10603 (10 mg) N-[4-[3-[[[7-(hydroxyamino)-7-oxoheptyl]amino]carbonyl]-5-isoxazolyl]phenyl]-1,1-dimethylethyl ester, carbamic acid; CAY10603
CAY10603 (5 mg) N-[4-[3-[[[7-(hydroxyamino)-7-oxoheptyl]amino]carbonyl]-5-isoxazolyl]phenyl]-1,1-dimethylethyl ester, carbamic acid; CAY10603
CAY10603 (500 ug) N-[4-[3-[[[7-(hydroxyamino)-7-oxoheptyl]amino]carbonyl]-5-isoxazolyl]phenyl]-1,1-dimethylethyl ester, carbamic acid; CAY10603
(E)-C-HDMAPP (ammonium salt) (1 mg) P’-[(3E)-5-hydroxy-4-methyl-3-penten-1-yl]-isohypophosphoric acid, triammonium salt; (E)-1-Hydroxy-2-Methylbut-2-enyl 4-Diphosphate (ammonium salt); (E)-C-HDMAPP (ammonium salt)
(E)-C-HDMAPP (ammonium salt) (10 mg) P’-[(3E)-5-hydroxy-4-methyl-3-penten-1-yl]-isohypophosphoric acid, triammonium salt; (E)-1-Hydroxy-2-Methylbut-2-enyl 4-Diphosphate (ammonium salt); (E)-C-HDMAPP (ammonium salt)
(E)-C-HDMAPP (ammonium salt) (5 mg) P’-[(3E)-5-hydroxy-4-methyl-3-penten-1-yl]-isohypophosphoric acid, triammonium salt; (E)-1-Hydroxy-2-Methylbut-2-enyl 4-Diphosphate (ammonium salt); (E)-C-HDMAPP (ammonium salt)
(E)-C-HDMAPP (ammonium salt) (500 ug) P’-[(3E)-5-hydroxy-4-methyl-3-penten-1-yl]-isohypophosphoric acid, triammonium salt; (E)-1-Hydroxy-2-Methylbut-2-enyl 4-Diphosphate (ammonium salt); (E)-C-HDMAPP (ammonium salt)
Chaetocin (1 mg) 2,2’,3S,3’S,5aR,5’aR,6,6’-octahydro-3,3’-bis(hydroxymethyl)-2,2’-dimethyl-[10bR,10’bR(11aS,11’aS)-bi-3,11a-epidithio-11aH-pyrazi’,2’:1,5]pyrrolo[2,3-b]indole]-1,1’,4,4’-tetrone; Chaetocin
Chaetocin (10 mg) 2,2’,3S,3’S,5aR,5’aR,6,6’-octahydro-3,3’-bis(hydroxymethyl)-2,2’-dimethyl-[10bR,10’bR(11aS,11’aS)-bi-3,11a-epidithio-11aH-pyrazi’,2’:1,5]pyrrolo[2,3-b]indole]-1,1’,4,4’-tetrone; Chaetocin
Chaetocin (5 mg) 2,2’,3S,3’S,5aR,5’aR,6,6’-octahydro-3,3’-bis(hydroxymethyl)-2,2’-dimethyl-[10bR,10’bR(11aS,11’aS)-bi-3,11a-epidithio-11aH-pyrazi’,2’:1,5]pyrrolo[2,3-b]indole]-1,1’,4,4’-tetrone; Chaetocin
JZL 184 (10 mg) 4-nitrophenyl-4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate; JZL 184
JZL 184 (100 mg) 4-nitrophenyl-4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate; JZL 184
JZL 184 (5 mg) 4-nitrophenyl-4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate; JZL 184
JZL 184 (50 mg) 4-nitrophenyl-4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate; JZL 184
AT-56 (1 mg) 4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-[4-(2H-tetrazol-5-yl)butyl]-piperidine; AT-56
AT-56 (10 mg) 4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-[4-(2H-tetrazol-5-yl)butyl]-piperidine; AT-56
AT-56 (5 mg) 4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-[4-(2H-tetrazol-5-yl)butyl]-piperidine; AT-56
AT-56 (50 mg) 4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-[4-(2H-tetrazol-5-yl)butyl]-piperidine; AT-56
7(S)-Maresin 1 (10 ug) 7S,14R-dihydroxy-4Z,8E,10Z,12Z,16Z,19Z-docosahexaenoic acid; 7(S)-MaR1|7-epi-Maresin 1; 7(S)-Maresin 1